查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1955469

2026年全球免疫血液學市場報告

Immunohematology Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，免疫血液學市場持續擴張，預計將從2025年的25.6億美元成長到2026年的26.9億美元，複合年成長率為4.9%。過去幾年的成長可歸因於血液疾病盛行率的上升、對安全輸血需求的成長、血庫的發展、診斷檢查室的擴張以及血液學試劑的進步。

預計未來幾年免疫血液學市場將維持強勁成長，2030年市場規模將達到32.7億美元，複合年成長率（CAGR）為5.0%。預測期內的成長要素包括分析儀器的技術創新、人工智慧在實驗室診斷中的應用、精準醫療的興起、數位醫療系統的整合以及血液篩檢計畫的擴展。預測期內的關鍵趨勢包括先進的血型鑑定技術、免疫血液學檢測的自動化、個人化輸血療法、照護現場免疫診斷以及實驗室資訊系統的整合。

預計未來幾年，社會老化將推動免疫血液學市場的擴張。社會老化指的是老年人口比例不斷上升的人口趨勢。免疫血液學在滿足老齡化的輸血需求、確保血液製品的安全使用以及支持老年人的各種醫療程序方面發揮關鍵作用。例如，根據美國非營利組織人口研究所的估計，截至2024年1月，美國65歲及以上人口預計將從2022年的5,800萬增至2050年的8,200萬，增幅達47%。同期，該年齡層佔總人口的比例預計將從17%增加到23%。因此，人口老化加劇正在推動免疫血液學市場的成長。

免疫血液學市場的主要企業正致力於開發創新診斷解決方案，例如可溶性重組蛋白，旨在克服抗癌藥物Daratumumab尤單抗（daratumumab）的干擾。可溶性重組蛋白採用重組DNA技術生產，在可溶性狀態下仍能維持正確的摺疊和功能，可有效用於診斷和治療。例如，西班牙製藥公司Grifols於2023年11月推出了Grifols sCD38溶液。本產品是首個專為解決Daratumumab對關鍵輸血相容性檢測的干擾而開發的可溶性重組蛋白。此溶液專為多發性骨髓瘤患者設計，可阻斷Daratumumab與紅血球表面CD38蛋白的結合，實現準確的輸血前檢測。透過改善篩檢、鑑定和交叉配對試驗，Grifols sCD38有助於提高輸血流程的效率，並減少救命血液製品的供應延誤。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球免疫血液學市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 先進的血型鑑定技術
    • 自動化免疫血液學檢測
    • 個人化輸血療法
    • 即時免疫診斷
    • 實驗室資訊系統整合

第5章 終端用戶產業市場分析

  • 血庫
  • 診斷與參考檢查室
  • 醫院
  • 學術研究機構
  • 診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球免疫血液學市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球免疫血液學市場規模、比較及成長率分析
  • 全球免疫血液學市場表現：規模與成長，2020-2025年
  • 全球免疫血液學市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 分析儀器及系統、試劑
  • 透過技術
  • 生物晶片、紅血球磁化技術（MET）、凝膠卡、微孔盤、聚合酵素鏈鎖反應（PCR）
  • 因疾病
  • 血液疾病、愛滋病、肝炎
  • 透過使用
  • 輸血前檢查、免疫溶血檢查、周產期檢查、血型表現型分析、白血球和血小板血清學檢查
  • 最終用戶
  • 血庫、診斷與參考檢查室、醫院、學術和研究機構
  • 按類型細分：分析儀器和系統
  • 血型鑑定設備、交叉配對試驗血設備、凝膠卡系統
  • 按類型細分：試劑
  • 血型鑑定試劑、抗血清、標準血清

第10章 區域與國家分析

  • 全球免疫血液學市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球免疫血液學市場：國家、績效及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 免疫血液學市場：競爭格局與市場佔有率（2024 年）
  • 免疫血液學市場：公司估值矩陣
  • 免疫血液學市場：公司概況
    • Ortho Clinical Diagnostics Inc.
    • Immunocor Inc.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Grifols SA

第37章：其他領先和創新企業

  • Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems SA, Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin SpA

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年免疫血液學市場：提供新機會的國家
  • 2030年免疫血液學市場：充滿新機會的細分市場
  • 2030年免疫血液學市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: PH5MIMMU04_G26Q1

Immunohematology is a specialized field of laboratory medicine that focuses on the study of blood groups and the immune system's response to foreign substances, particularly in the context of blood transfusions. Immunohematological techniques are applied to identify and resolve diagnostic challenges in patients with blood-related disorders, such as autoimmune hemolytic anemia.

The main products in immunohematology include analyzers, systems, and reagents. Analyzers and systems are automated instruments used for blood typing and antibody screening. The technologies employed include biochips, erythrocyte-magnetized technology (EMT), gel cards, microplates, and polymerase chain reaction (PCR), which are used in the diagnosis and management of diseases such as HIV and hepatitis. The key applications include pretransfusion testing, investigation of immune hemolysis, perinatal testing, blood group phenotyping, and leukocyte and platelet serology, and these are utilized by end users such as blood banks, diagnostic and reference laboratories, hospitals, and academic and research institutes.

Tariffs have affected the immunohematology market by increasing the cost of imported analyzers, reagents, and lab equipment, leading to higher operational expenses for diagnostic laboratories and hospitals. Segments such as analyzers and reagents are most impacted, particularly in regions like North America and Europe, which rely on imports from Asia-Pacific manufacturing hubs. While tariffs have created cost pressures, they have also encouraged local production and innovation, driving the development of cost-efficient domestic immunohematology solutions.

The immunohematology market research report is one of a series of new reports from The Business Research Company that provides immunohematology market statistics, including immunohematology industry global market size, regional shares, competitors with a immunohematology market share, detailed immunohematology market segments, market trends and opportunities, and any further data you may need to thrive in the immunohematology industry. This immunohematology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohematology market size has grown steadily in recent years. It will grow from $2.56 billion in 2025 to $2.69 billion in 2026 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to increasing prevalence of blood disorders, rising demand for safe blood transfusions, development of blood banks, growth in diagnostic laboratories, advancements in hematology reagents.

The immunohematology market size is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to technological advancements in analyzers, adoption of AI in laboratory diagnostics, rise in precision medicine, integration of digital health systems, expansion of blood screening programs. Major trends in the forecast period include advanced blood typing techniques, automation in immunohematology testing, personalized transfusion therapy, point-of-care immune diagnostics, integration of laboratory information systems.

The growing aging population is anticipated to drive the expansion of the immunohematology market in the coming years. An aging population describes a demographic trend marked by a rising proportion of elderly individuals within a society. Immunohematology plays a critical role in meeting age-related transfusion requirements, ensuring the safe use of blood products, and supporting a wide range of medical procedures for older adults. For example, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization, the number of Americans aged 65 years and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. During the same period, this age group's share of the total population is expected to grow from 17% to 23%. Therefore, the expanding aging population is contributing to the growth of the immunohematology market.

Major companies operating in the immunohematology market are focusing on the development of innovative diagnostic solutions, such as soluble recombinant proteins designed to overcome interference caused by the cancer therapy daratumumab. A soluble recombinant protein is produced using recombinant DNA technology and remains properly folded and functional in a soluble form, enabling its effective use in diagnostic and therapeutic applications. For instance, in November 2023, Grifols, S.A., a Spain-based pharmaceutical company, launched the Grifols sCD38 solution. This product is the first soluble recombinant protein developed to address the interference caused by daratumumab during critical blood transfusion compatibility testing. Designed specifically for patients with multiple myeloma, the solution blocks daratumumab from binding to CD38 proteins on red blood cells, enabling accurate pre-transfusion test results. By improving screening, identification, and crossmatching processes, Grifols sCD38 helps streamline transfusion workflows and reduce delays in delivering lifesaving blood products.

In March 2023, Werfen S.A., a Spain-based diagnostic care company, acquired Immucor Inc. for approximately $2 billion. This acquisition was intended to strengthen Werfen's capabilities in specialized diagnostic testing, particularly in transfusion and immunohematology solutions. Immucor Inc. is a transfusion diagnostics company focused on providing safe, accessible, and reliable blood testing technologies.

Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immunohematology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunohematology market includes revenues earned by entities by providing blood banking and transfusion medicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohematology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immunohematology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohematology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunohematology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Analyzers And Systems; Reagents
  • 2) By Technology: Biochips; Erythrocyte-Magnetized Technology (Met); Gel Cards; Microplates; Polymerase Chain Reaction (PCR)
  • 3) By Disease: Blood-Related Diseases; HIV; Hepatitis
  • 4) By Application: Pretransfusion Testing; Investigation Of Immune Hemolysis; Perinatal Testing; Blood Group Phenotyping; Leucocyte And Platelet Serology
  • 5) By End User: Blood Banks; Diagnostic And Reference Laboratories; Hospitals; Academic And Research Institutes
  • Subsegments:
  • 1) By Analyzers And Systems: Blood Typing Analyzers; Cross-Matching Analyzers; Gel Card Systems
  • 2) By Reagents: Blood Grouping Reagents; Antisera; Control Serum
  • Companies Mentioned: Ortho Clinical Diagnostics Inc.; Immunocor Inc.; Abbott Laboratories; Siemens Healthineers AG; Grifols S.A.; Beckman Coulter Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson and Company; Merck Co. & KGaA; Bio-Rad Laboratories; Sysmex Corporation; Danaher Corporation; Biosystems S.A.; Roche Holdings AG; Mindray Medical International Limited; F.Hoffmann La-Roche Ltd.; Biotest AG; Cardinal Health Inc.; Quotient Limited; DiaSorin S.p.A.; Lorne Laboratories Ltd.; Biokit S.A.; Avox Technologies; Diagnostic Automation/Cortez Diagnostics Inc.; Inno-train Diagnostik GmbH; Drucker Diagnostics Inc.; Immundia Diagnostics Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Immunohematology Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Immunohematology Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Immunohematology Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Immunohematology Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Advanced Blood Typing Techniques
    • 4.2.2 Automation In Immunohematology Testing
    • 4.2.3 Personalized Transfusion Therapy
    • 4.2.4 Point-Of-Care Immune Diagnostics
    • 4.2.5 Integration Of Laboratory Information Systems

5. Immunohematology Market Analysis Of End Use Industries

  • 5.1 Blood Banks
  • 5.2 Diagnostic And Reference Laboratories
  • 5.3 Hospitals
  • 5.4 Academic And Research Institutes
  • 5.5 Clinics

6. Immunohematology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunohematology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Immunohematology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Immunohematology Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Immunohematology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Immunohematology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunohematology Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunohematology Market Segmentation

  • 9.1. Global Immunohematology Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Analyzers And Systems, Reagents
  • 9.2. Global Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
  • 9.3. Global Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood-Related Diseases, HIV, Hepatitis
  • 9.4. Global Immunohematology Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
  • 9.5. Global Immunohematology Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes
  • 9.6. Global Immunohematology Market, Sub-Segmentation Of Analyzers And Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
  • 9.7. Global Immunohematology Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Grouping Reagents, Antisera, Control Serum

10. Immunohematology Market Regional And Country Analysis

  • 10.1. Global Immunohematology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Immunohematology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunohematology Market

  • 11.1. Asia-Pacific Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunohematology Market

  • 12.1. China Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunohematology Market

  • 13.1. India Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunohematology Market

  • 14.1. Japan Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunohematology Market

  • 15.1. Australia Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunohematology Market

  • 16.1. Indonesia Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunohematology Market

  • 17.1. South Korea Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunohematology Market

  • 18.1. Taiwan Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunohematology Market

  • 19.1. South East Asia Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunohematology Market

  • 20.1. Western Europe Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunohematology Market

  • 21.1. UK Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunohematology Market

  • 22.1. Germany Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunohematology Market

  • 23.1. France Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunohematology Market

  • 24.1. Italy Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunohematology Market

  • 25.1. Spain Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunohematology Market

  • 26.1. Eastern Europe Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunohematology Market

  • 27.1. Russia Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunohematology Market

  • 28.1. North America Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunohematology Market

  • 29.1. USA Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunohematology Market

  • 30.1. Canada Immunohematology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunohematology Market

  • 31.1. South America Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunohematology Market

  • 32.1. Brazil Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunohematology Market

  • 33.1. Middle East Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunohematology Market

  • 34.1. Africa Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Immunohematology Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunohematology Market Regulatory and Investment Landscape

36. Immunohematology Market Competitive Landscape And Company Profiles

  • 36.1. Immunohematology Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Immunohematology Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Immunohematology Market Company Profiles
    • 36.3.1. Ortho Clinical Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Immunocor Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Immunohematology Market Other Major And Innovative Companies

  • Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A.

38. Global Immunohematology Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immunohematology Market

40. Immunohematology Market High Potential Countries, Segments and Strategies

  • 40.1 Immunohematology Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Immunohematology Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Immunohematology Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer